BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gidwaney NG, Pawa S, Das KM. Pathogenesis and clinical spectrum of primary sclerosing cholangitis. World J Gastroenterol 2017; 23(14): 2459-2469 [PMID: 28465630 DOI: 10.3748/wjg.v23.i14.2459]
URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2459.htm
Number Citing Articles
1
Raquel T. Yokoda, Elizabeth J. Carey. Primary Biliary Cholangitis and Primary Sclerosing CholangitisAmerican Journal of Gastroenterology 2019; 114(10): 1593 doi: 10.14309/ajg.0000000000000268
2
Carlo Selmi, Elena Generali, Merrill Eric Gershwin. Rheumatic Manifestations in Autoimmune Liver DiseaseRheumatic Disease Clinics of North America 2018; 44(1): 65 doi: 10.1016/j.rdc.2017.09.008
3
Bettina M Buchholz, Panagis M Lykoudis, Reena Ravikumar, Joerg M Pollok, Giuseppe K Fusai. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipientsWorld Journal of Gastroenterology 2018; 24(28): 3171-3180 doi: 10.3748/wjg.v24.i28.3171
4
Johanna Schönau, Axel Wester, Jörn M. Schattenberg, Hannes Hagström. Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population‐based cohort studyJournal of Internal Medicine 2023; 294(2): 164 doi: 10.1111/joim.13624
5
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disordersWorld Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
6
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Colangitis esclerosante primaria y enfermedad inflamatoria intestinal: interrelación intestino-hígadoGastroenterología y Hepatología 2019; 42(5): 316 doi: 10.1016/j.gastrohep.2019.02.004
7
Chris M. Li, Zhibin Chen. Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 InflammationFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.664305
8
Lucas Rocha ALVARENGA, Natascha Silva SANDY, Gabriela Souza GOMEZ, Gabriel HESSEL, Adriana Maria Alves DE TOMMASO, Maria Ângela BELLOMO-BRANDÃO. SYMPTOMATIC CHOLELITHIASIS AS THE PRESENTATION OF PEDIATRIC PRIMARY SCLEROSING CHOLANGITIS - CASE SERIES AND LITERATURE REVIEWArquivos de Gastroenterologia 2021; 58(2): 227 doi: 10.1590/s0004-2803.202100000-41
9
Damjana Bogatic, Robert V. Bryant, Kate D. Lynch, Samuel P. Costello. Systematic review: microbial manipulation as therapy for primary sclerosing cholangitisAlimentary Pharmacology & Therapeutics 2023; 57(1): 23 doi: 10.1111/apt.17251
10
Marica Cariello, Raffaella M. Gadaleta, Antonio Moschetta. The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatmentCurrent Opinion in Gastroenterology 2022; 38(2): 136 doi: 10.1097/MOG.0000000000000807
11
Leilei Yu, Yaru Liu, Shunhe Wang, Qingsong Zhang, Jianxin Zhao, Hao Zhang, Arjan Narbad, Fengwei Tian, Qixiao Zhai, Wei Chen. Cholestasis: exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategiesGut Microbes 2023; 15(1) doi: 10.1080/19490976.2023.2181930
12
Marco Fiore, Sebastiano Leone, Alberto Enrico Maraolo, Emilio Berti, Giovanni Damiani. Liver Illness and Psoriatic PatientsBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3140983
13
Xiaojiaoyang Li, Runping Liu, Zhiming Huang, Emily C. Gurley, Xuan Wang, Juan Wang, Hongliang He, Hu Yang, Guanhua Lai, Luyong Zhang, Jasmohan S. Bajaj, Melanie White, William M. Pandak, Phillip B. Hylemon, Huiping Zhou. Cholangiocyte‐derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humansHepatology 2018; 68(2): 599 doi: 10.1002/hep.29838
14
І.В. Бєлінська, Г.М. Кузнєцова, Н.В. Дзюбенко, Ю.В. Савич, Д.С. Мілохов, О.В. Хиля, Т.В. Рибальченко. Застосування 1-(4-Cl-бензил)-3-Cl-4-(CF3-феніламіно)- 1Н-пірол-2,5-діону як панспецифічного інгібітора протеїнкіназ для гальмування гематологічних ускладнень на тлі експериментального хронічного холангіту у щурівReports of the National Academy of Sciences of Ukraine 2021; (4): 94 doi: 10.15407/dopovidi2021.04.094
15
Serena Babboni, Pier Giuseppe Vacca, Ludovica Simonini, Daniele Pezzati, Caterina Martinelli, Francesco Frongillo, Giuseppe Bianco, Emanuele Marciano, Giuseppina Basta, Davide Ghinolfi, Serena Del Turco. Cholangiocyte Organoids: The New Frontier in Regenerative Medicine for the Study and Treatment of CholangiopathiesJournal of Clinical Medicine 2024; 13(6): 1804 doi: 10.3390/jcm13061804
16
Nelli Sjöblom, Sonja Boyd, Hannu Kautiainen, Johanna Arola, Martti Färkkilä. Novel histological scoring for predicting disease outcome in primary sclerosing cholangitisHistopathology 2022; 81(2): 192 doi: 10.1111/his.14677
17
Jian Zhang, Huiwen Wang, Jinqing Liu, Lei Fu, Shifang Peng. ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitisHuman Genomics 2023; 17(1) doi: 10.1186/s40246-023-00534-z
18
Paulina Núñez F., Rodrigo Quera P., Fernando Gomollón. Primary sclerosing cholangitis and inflammatory bowel disease: Intestine–liver interrelationGastroenterología y Hepatología (English Edition) 2019; 42(5): 316 doi: 10.1016/j.gastre.2019.02.030
19
Ji-Won Park, Jung-Hee Kim, Sung-Eun Kim, Jang Han Jung, Myoung-Kuk Jang, Sang-Hoon Park, Myung-Seok Lee, Hyoung-Su Kim, Ki Tae Suk, Dong Joon Kim. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and TherapeuticsBiomedicines 2022; 10(6): 1288 doi: 10.3390/biomedicines10061288
20
Areej Mazhar, Syed-Mohammed Jafri. Small Duct Primary Sclerosing CholangitisAmerican Journal of Gastroenterology 2017; 112: S1512 doi: 10.14309/00000434-201710001-02808
21
Xiaojiaoyang Li, Runping Liu, Yanyan Wang, Weiwei Zhu, Derrick Zhao, Xuan Wang, Hang Yang, Emily C. Gurley, Weidong Chen, Phillip B. Hylemon, Huiping Zhou. Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic ConditionsCells 2020; 9(1): 190 doi: 10.3390/cells9010190
22
Fady M Wadea. Small Duct Sclerosing Cholangitis: A Case Report and Review of LiteratureGastroenterology & Hepatology: Open Access 2017; 8(2) doi: 10.15406/ghoa.2017.08.00272
23
Qing-Ling Chen, Rui Zhong, Xiao-Xue Zhang, Li-Na Feng, Xiao-Yu Wen, Qing-Long Jin. Primary sclerosing cholangitis with increased immunoglobulin G4 levelsMedicine 2019; 98(50): e18411 doi: 10.1097/MD.0000000000018411
24
Richard Kellermayer, Marco Carbone, Thomas D. Horvath, Reka G. Szigeti, Cynthia Buness, Gideon M. Hirschfield, Peter J. Lewindon. Identifying a therapeutic window of opportunity for people living with primary sclerosing cholangitis: Embryology and the overlap of inflammatory bowel disease with immune-mediated liver injuryHepatology 2024;  doi: 10.1097/HEP.0000000000000926